Nick Delmonico is the co-founder and CEO of Strados Labs and a former pediatric asthma patient. Prior to Strados Labs, Nick worked in financial consulting at a Fortune 100 financial institution and in public accounting at a Big Four firm. During this time, Nick worked with multinational pharmaceutical companies, biotechnology firms, and large hospitals and health systems in the greater Philadelphia area. He received his master’s degree in Healthcare Management from Temple University’s Fox School of Business.

Richard Powers is the Chief Product Officer and cofounder of Strados Labs, where he leads product innovation and technical strategy. With over 25 years of experience in FDA-regulated medical device development, Richard has worked across Class III implantables, wearable sensors, and AI-driven respiratory diagnostics. He began his MedTech career at CardioMEMS as a graduate intern and advanced to CIO before co-founding Strados. Richard holds an M.S. in Electrical and Computer Engineering and an MBA from Georgia Tech.

Jason Kroh serves as Chief Technology Officer of Strados Labs, where he leads technology design, development, and manufacturing. He brings more than 25 years of experience in senior R&D and executive roles at innovative medical device start-ups. His expertise spans Class III implantable devices, combination products, and advanced novel wearable technologies. Recognized for his technical depth, Jason serves as an ongoing NSF grant reviewer, influencing the direction of emerging technologies.

Matt McCarty serves as Chief Commercial Officer of Strados Labs, where he leads sales, marketing, partnerships, and commercial strategy. He brings nearly 20 years of experience across life sciences and clinical trials, including leadership roles at global contract research organizations and senior executive experience within the clinical trial endpoint market.

Matt has worked extensively with pharmaceutical sponsors, biotechnology companies, and CROs on the adoption and scale-up of respiratory endpoints and decentralized data collection in clinical trials. He is drawn to Strados’ RESP® platform and its expansion from cough and lung sound measurement into a broader ecosystem of respiratory trial solutions.

Dr. Tom deLaubenfels has worked for over 7 years in the space of remote patient monitoring and longitudinal physiological data analysis. He is responsible for directing technical R&D, studies, and publications which advance the field of remote longitudinal lung sound and physiological data monitoring. Before joining Strados he was a technical R&D project lead at LifeQ for a variety of physiological monitoring projects. He is an expert in the development of computational systems that benefit human health.

Shane Krauss is the Global Director, Life Science at Strados Labs, where he leads global commercial strategy and enterprise partnerships across life sciences. Since joining in 2021, he has built and scaled the company’s commercial organization, driving international expansion and embedding the FDA-cleared RESP® biosensor into multi-country clinical programs spanning Phase 1–3. Shane brings 20 years of healthcare leadership across medical devices, enterprise SaaS, telehealth, and post-acute care. He is known for translating complex clinical and workflow needs into scalable commercial execution, and he partners cross-functionally with product, engineering, and marketing teams to align roadmap, positioning, and deployment delivery with sponsor requirements and evolving digital biomarker priorities.

Rachel Hollatz is the Annotation Manager for Strados Labs, leading a dedicated team of specialists who provide expert review and interpretation of lung sound data. She is a Registered Respiratory Therapist with over 15 years of experience working in health systems including Ministry Health Care and Marshfield Clinic Health System.

Devan Parson brings to the team a wealth of experience of managing complex phase I and phase II trials testing investigational products, gained through her pivotal work during the COVID-19 pandemic. Prior to joining Strados, Devan played a key role in feasibility studies evaluating the RESP® Biosensor on initial patients, serving as a clinical research coordinator with a Strados Labs partner organization. Devan holds an MBA from Pierce College.

Dr. Au serves as the clinical lead for clinical operations and provides clinical inputs on sales and marketing strategy. He completed his clinical training at Thomas Jefferson University Hospital. Prior to his career in medicine, he was a management consultant in top firms in New York and Boston. He holds a BS in Biomedical Engineering from Brown University and an MD from Case Western Reserve University at Cleveland, Ohio.